Condition

Non-prostate Extrapulmonary Neuroendocrine Carcinoma

ClinicalTrials.gov condition label

Clinical trials1

Recruiting1

Common interventions2

Lead sponsors shown1

Clinical trials

1 shown

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid TumorsNCT07006727 · 2025-10-16

RECRUITING

Common interventions

111In-ETN029DRUG1225Ac-ETN029DRUG1

Leading sponsors

Novartis Pharmaceuticals1

Trial status mix

RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.